We are live on ! Find out more
MLAB icon

Mesa Laboratories

175 hedge funds and large institutions have $1.24B invested in Mesa Laboratories in 2022 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 69 increasing their positions, 57 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

21% more repeat investments, than reductions

Existing positions increased: 69 | Existing positions reduced: 57

0.95% more ownership

Funds ownership: 91.62%92.56% (+0.95%)

0% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 17

2% less funds holding

Funds holding: 178175 (-3)

21% less capital invested

Capital invested by funds: $1.57B → $1.24B (-$331M)

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

Holders
175
Holders Change
-3
Holders Change %
-1.69%
% of All Funds
2.76%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
17
Increased
69
Reduced
57
Closed
17
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$236M +$1.1M +4,061 +0.4%
CCA
2
Conestoga Capital Advisors
Pennsylvania
$133M +$1.83M +6,752 +1%
RA
3
Royce & Associates
New York
$90.9M +$3.77M +13,885 +4%
Vanguard Group
4
Vanguard Group
Pennsylvania
$87M +$1.21M +4,464 +1%
Invesco
5
Invesco
Georgia
$70.7M +$515K +1,898 +0.7%
State Street
6
State Street
Massachusetts
$50.3M +$1.7M +6,249 +3%
RIM
7
Ranger Investment Management
Texas
$43M +$1.45M +5,350 +3%
Kayne Anderson Rudnick Investment Management
8
Kayne Anderson Rudnick Investment Management
California
$39.2M -$808K -2,976 -2%
ACM
9
Atlanta Capital Management
Georgia
$34.5M -$127K -466 -0.3%
Schroder Investment Management Group
10
Schroder Investment Management Group
United Kingdom
$30.3M -$807K -2,971 -2%
Principal Financial Group
11
Principal Financial Group
Iowa
$28.7M +$5.98M +22,017 +24%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$23.7M +$719K +2,648 +3%
Northern Trust
13
Northern Trust
Illinois
$21.2M +$308K +1,135 +1%
GT
14
Glenmede Trust
Pennsylvania
$18.7M -$35.3K -130 -0.2%
Ameriprise
15
Ameriprise
Minnesota
$18.6M +$634K +2,333 +3%
EAM
16
Eagle Asset Management
Florida
$16.2M -$662K -2,438 -4%
Dimensional Fund Advisors
17
Dimensional Fund Advisors
Texas
$15.6M +$925K +3,405 +6%
GIM
18
Granahan Investment Management
Massachusetts
$14.6M +$2.89M +10,649 +23%
Wells Fargo
19
Wells Fargo
California
$14.4M +$5.73M +21,098 +59%
Bank of New York Mellon
20
Bank of New York Mellon
New York
$14M -$1.15M -4,233 -7%
DDC
21
DF Dent & Co
Maryland
$13.1M -$2.55M -9,402 -15%
FAM
22
Fred Alger Management
New York
$12.8M -$72.5K -267 -0.5%
Russell Investments Group
23
Russell Investments Group
United Kingdom
$12.5M -$733K -2,699 -5%
Comerica Bank
24
Comerica Bank
Texas
$11.5M +$241K +886 +2%
MAP
25
Moody Aldrich Partners
Massachusetts
$10.8M +$1.21M +4,456 +12%

MLAB Hedge Fund Activity: Q1 2022 in Review

175 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Mesa Laboratories (MLAB) for Q1 2022, worth a combined $1.24B — down 21% from $1.57B a quarter earlier.

Fund positioning in MLAB was balanced in Q1 2022: 17 funds opened new positions, 17 closed out, 69 added to existing stakes and 57 trimmed.

The largest buyer was Principal Financial Group, adding an estimated $5.98M. The largest seller was EAM Investors, exiting entirely with an estimated $3.18M sold.

  • 175 institutional investors held Mesa Laboratories (MLAB) as of Q1 2022, down from 178 in Q4 2021.
  • Funds reported $1.24B of Mesa Laboratories stock for Q1 2022, down 21% quarter-over-quarter.
  • 17 funds opened new Mesa Laboratories positions in Q1 2022 and 17 closed out, a net change of 0 holders.
  • The largest Mesa Laboratories buyer in Q1 2022 was Principal Financial Group, an estimated $5.98M added.
  • The largest Mesa Laboratories seller in Q1 2022 was EAM Investors, an estimated $3.18M sold.

Based on aggregated 13F filings for Q1 2022.